bioRxivMicrobiology
Phosphorus stress induces the synthesis of novel glycolipids in Pseudomonas aeruginosa that confer protection against a last-resort antibiotic
R. Jones, H. Shropshire, C. Zhao, A. Murphy, I. Lidbury, T. Wei, D. J. Scanlan, Y. Chen
Abstract
Pseudomonas aeruginosa is a nosocomial pathogen with a prevalence in immunocompromised individuals and is particularly abundant in the lung microbiome of cystic fibrosis patients. A clinically important adaptation for bacterial pathogens during infection is their ability to survive and proliferate under phosphorus (P) limited growth conditions. Here, we demonstrate that P. aeruginosa adapts to P-limitation by substituting membrane glycerophospholipids with sugar-containing glycolipids through a lipid renovation pathway involving a phospholipase and two glycosyltransferases. Combining bacterial genetics and multi-omics (proteomics, lipidomics and metatranscriptomic analyses), we show that the surrogate glycolipids monoglycosyldiacylglycerol and glucuronic acid-diacylglycerol are synthesised through the action of a new phospholipase (PA3219) and two glycosyltransferases (PA3218 and PA0842). Comparative genomic analyses revealed that this pathway is strictly conserved in all P. aeruginosa strains isolated from a range of clinical and environmental settings and actively expressed in the metatranscriptome of a cystic fibrosis patient. Importantly, this phospholipid-to-glycolipid transition comes with significant ecophysiological consequence in terms of antibiotic sensitivity. Mutants defective in glycolipid synthesis survive poorly when challenged with polymyxin B, a last-resort antibiotic for treating multi-drug resistant P. aeruginosa. Thus, we demonstrate an intriguing link between adaptation to environmental stress (nutrient availability) and antibiotic resistance, mediated through membrane lipid renovation that is an important new facet in our understanding of the ecophysiology of this bacterium in the lung microbiome of cystic fibrosis patients. ClassificationIntegrated genomics and post-genomics approaches in microbial ecology
- organism: bacteria (other)
- assay: proteomics
- assay: metagenomics
- assay: metabolomics
- research focus: cell type annotation
- research focus: gene regulatory network inference
- research focus: drug response / drug discovery
- approach: genetic perturbation / CRISPR
- approach: statistical model
- approach: comparative / phylogenetic analysis
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Activation of the Pseudomonas aeruginosa Glycerol Regulon Promotes Antibiotic Persistence and Modulates Virulence Phenotypes
Nicholas J. Evans, Jessica A. Scoffield·bioRxiv·Apr 14, 2025
- Cystic Fibrosis Acidic Microenvironment Determines Antibiotic Susceptibility and Biofilm Formation of Pseudomonas aeruginosa
Q. Lin, J. M. Pilewski, Y. P. Di·bioRxiv·Oct 15, 2020
- Alternative lipid synthesis in response to phosphate limitation promotes antibiotic tolerance in Gram-negative ESKAPE pathogens
Roberto Jhonatan Olea‐Ozuna, Melanie J. Campbell, … Joseph M. Boll·PLoS PathogensPeer-reviewed·Feb 7, 2025
- Pseudomonas aeruginosa utilises host-derived polyamines to facilitate antimicrobial tolerance
C. M. Hasan, A. Green, … J. L. Fothergill·bioRxiv·Dec 15, 2021
- Biofilm-deficient mutants of Pseudomonas aeruginosa have wild-type levels of antibiotic tolerance in a model of cystic fibrosis lung infection
Jenny L. Littler, Niamh E. Harrington, … Freya Harrison·bioRxiv·Jul 16, 2026
- pH-Dependent Evolution of Delafloxacin and Ciprofloxacin Resistance in Pseudomonas aeruginosa from cystic fibrosis (CF) and non-CF-patients
Niranjan R. Ireddy, Anja Bösch, … Baharak Babouee Flury·bioRxiv·Sep 9, 2026